Loading
MC
Mountain Crest Acquisition Corp. V Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Liu Suying, was filed 22 Nov 2021.
Mountain Crest Acquisition Corp. V: what insiders have been doing
Mountain Crest Acquisition Corp. V, classified in the Finance & Banking sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (23 October 2025 to 23 October 2026), 1 filing came from 1 insider.
There is no open-market purchase to report; the filings show 1 sale worth €849k by 1 insider. At €849k, the sale published on 2 January 2026 by Liu Suying is the largest of the period.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 1 filing in twelve months, the company is quieter than the median of 8 filings across the 279 companies we follow on the same exchange. Our records for Mountain Crest Acquisition Corp. V go back to 2021, with 2 purchases and 3 sales on the open market in total. For the fiscal year to 31 December 2025, the annual 10-K puts net income at -431,161 USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at BAWAG Group AG and ASR Nederland N.V. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
16
Thresholds
n/a
Buy Volume
€2M
2 ops. · all time
Sell Volume
€3M
3 ops. · all time
Who traded when
BuySaleSuying Liu2 sales
Since the insiders bought
- +0.4%Entry US$10.06 · Close at T+365 US$10.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$15.00
Analyst consensus
Income statement
EBITDA-US$422.3k
Net income-US$431.2k0.0% margin
Valuation
Beta0.06
Balance sheet & cash
Market capUS$43.1M
Total debtUS$1.3M
Free Cash Flow-US$742k
Profitability & ownership
ROA-22.1%
% insiders72.2%
% institutions0.0%
Last declaration on 2 January 2026
Declarations16 total
200,000 shares@ US$5.0018.9% of flowCommon StockSEC:0001829126-26-000026:0
200,000 shares@ US$5.0018.9% of flowCommon StockSEC:0001829126-26-000025:0
▼
Same trade as the filing by Suying Liu, counted once
700,000 USD15SEC
100,000 shares@ US$7.0014.8% of flowCommon StockSEC:0001829126-25-001111:0
100,000 shares@ US$7.0014.8% of flowCommon StockSEC:0001829126-25-001112:0
2,165,800 sharesCommon StockSEC:0001829126-24-004707:0
2,165,800 sharesCommon StockSEC:0001829126-24-004708:0
150,000 sharesCommon StockSEC:0001829126-24-002732:0
75,000 sharesCommon StockSEC:0001829126-23-006223:0
100,000 sharesCommon StockSEC:0001829126-23-004267:0
1,840,800 sharesCommon StockSEC:0001829126-23-002343:0
100,000 shares@ US$10.0022.7% of flowCommon StockSEC:0001829126-22-018180:0
100,000 shares@ US$10.0022.7% of flowCommon StockSEC:0001829126-22-018181:0
18,000 shares@ US$10.003.5% of flowCommon StockSEC:0001829126-21-014655:0
Canonical exit: 16 Feb 2022 (T+90)
▲
Same trade as the filing by Suying Liu, counted once
180,000 USD16SEC
18,000 shares@ US$10.003.5% of flowCommon StockSEC:0001829126-21-014654:0
Canonical exit: 16 Feb 2022 (T+90)
205,000 shares@ US$10.0040.1% of flowCommon StockSEC:0001829126-21-014400:0
Canonical exit: 14 Feb 2022 (T+90)
205,000 shares@ US$10.0040.1% of flowCommon StockSEC:0001829126-21-014401:0
Canonical exit: 14 Feb 2022 (T+90)
16 of 16 declarations
About Mountain Crest Acquisition Corp. V
Mountain Crest Acquisition Corp. V is a U.S.-listed special purpose acquisition company (SPAC) incorporated in Delaware and headquartered in New York, United States. It completed its IPO on the Nasdaq in November 2021 under the ticker MCAG, while the rights traded separately under MCAGU. In the current SEC reporting framework, MCAGU is visible primarily through insider-ownership disclosures such as Form 4 filings, which is consistent with a blank-check vehicle whose market story is driven by merger execution rather than operating earnings. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/mountaincrest5_10k.htm))
From a business-model perspective, Mountain Crest V does not function like a traditional industrial or consumer company. Its sole purpose is to identify, negotiate, and consummate a business combination with one or more operating businesses through a merger, share exchange, asset acquisition, stock purchase, recapitalization, or similar transaction. SEC filings state that, since the IPO, the company’s only substantive activity has been identifying and evaluating suitable acquisition candidates. That means the equity case is inherently event-driven: upside depends on closing a transaction, while downside risk remains tied to delay, dilution, financing needs, and the possibility that no deal is completed. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/mountaincrest5_10k.htm))
Read moreShow less
The company’s history is closely linked to the broader Mountain Crest SPAC platform. A company filing in August 2024 describes Mountain Crest V as the fifth vehicle in the Mountain Crest family of SPACs and notes that management had previously completed four prior SPAC business combinations. On August 29, 2024, Mountain Crest V announced a definitive business combination agreement with CUBEBIO Co., Ltd., a Korean company developing early cancer-detection technology based on urine analysis. The contemplated post-transaction company is expected to be listed on the Nasdaq, underscoring the cross-border nature of the deal. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1859035/000182912624005987/mountaincrest5_ex99-1.htm?utm_source=openai))
In terms of competitive positioning, Mountain Crest V operates in a crowded SPAC market where sponsor credibility, deal sourcing, valuation discipline, and the ability to navigate SEC and shareholder approvals are the main differentiators. Its geographic footprint is largely U.S.-based, with New York as the operating center, but its target universe is international, as shown by the CUBEBIO transaction spanning the United States, South Korea, and Cayman Islands holding-company structures. Recent corporate developments include an extension of the business-combination deadline to November 16, 2026, a later SEC filing indicating the securities were moved from Nasdaq to OTC Pink after delisting, and ongoing insider transactions reported through Form 4. Those items suggest a company still focused on completing a transaction rather than generating conventional operating revenue. ([investing.com](https://www.investing.com/news/sec-filings/mountain-crest-acquisition-corp-v-extends-business-combination-deadline-to-november-2026-93CH-4344198?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
